专利名称：Multigene prognostic assay for lung cancer发明人：Mann, Michael J.,Jablons, David M.,Kratz,
Johannes,Berryman, David
申请号：AU2012279173申请日：20120629公开号：AU2012279173A1公开日：20130509
摘要：The present invention provides methods for providing a prognosis for lungcancer using a panel of eleven molecular markers that includes BAG1, BRCA1, CDC6,CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, and WNT3A, which are differentiallyexpressed in lung cancer. The eleven markers are related to patient prognosis to 5 -yearoverall survival outcomes, and are particularly useful in providing a prognosis for non-squamous NSCLC.
申请人：The Regents of the University of California,Pinpoint Genomics, Inc.
代理人：FB Rice
更多信息请下载全文后查看
因篇幅问题不能全部显示，请点此查看更多更全内容
Copyright © 2019- stra.cn 版权所有 赣ICP备2024042791号-4
违法及侵权请联系：TEL:199 1889 7713 E-MAIL:2724546146@qq.com
本站由北京市万商天勤律师事务所王兴未律师提供法律服务